Cabaletta Bio Q1 EPS $(0.45) Beats $(0.48) Estimate; Cash & Cash Equivalents Of $93.8M Will Enable The Company To Fund Its Operating Plan Into Q1 Of 2025

Benzinga · 05/11/2023 11:14
Cabaletta Bio (NASDAQ:CABA) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.48) by 6.25 percent. This is unchanged from the same period last year.